Skip to Main Content

Paper Details

Development of a Benzothiazole Scaffold-Based Androgen Receptor N-Terminal Inhibitor for Treating Androgen-Responsive Prostate Cancer.
ACS Chem Biol
7
2021
  • 1 - 2

Datasets